1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
Key Takeaways
Cerebral blood flow (CBF ≈ 50 mL/100g/min) is autoregulated between Mean Arterial Pressures (MAP) of 50-150 mmHg; the curve shifts to the right in chronic hypertension.
CBF changes linearly by 1-2 mL/100g/min per 1 mmHg change in PaCO₂ between 20-80 mmHg; hyperventilation (PaCO₂ 30-35 mmHg) provides rapid, transient reduction in ICP.
Cerebral Perfusion Pressure is calculated as CPP = MAP - ICP (or CVP, whichever is higher); normal adult ICP is 5-15 mmHg, and target CPP during neurotrauma is 60-70 mmHg.
Autonomic hyperreflexia occurs in spinal cord injuries at or above T6 in response to cutaneous or visceral stimulation below the lesion, producing severe hypertension with reflex bradycardia.
Myasthenia Gravis involves postsynaptic nicotinic AChR destruction (resistant to succinylcholine, exquisitely sensitive to non-depolarizers), whereas Lambert-Eaton involves presynaptic VGCC antibodies (sensitive to BOTH depolarizing and non-depolarizing NMBAs).
1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
Safe neuroanesthesia and perioperative neurologic care depend on preserving cerebral perfusion pressure, controlling intracranial dynamics, and managing autonomic and neuromuscular junction pathologies.
1. Cerebral Blood Flow (CBF) & Autoregulation
- Normal Global CBF: (approximately , or of total resting cardiac output).
- Cortical Gray Matter:
- Subcortical White Matter:
- Cerebral Metabolic Rate for Oxygen (): (accounts for of total body resting oxygen consumption).
+-------------------------------------------------------------------------+
| CEREBRAL BLOOD FLOW AUTOREGULATION |
+-------------------------------------------------------------------------+
| |
| CBF (mL/100g/min) |
| 100 | +-----------------------+ (Hyperperfusion) |
| | / \ |
| 50 |----------------+ AUTOREGULATION PLATEAU +----------------- |
| | / (50 - 150 mmHg MAP) \ |
| 0 +--------------+-------------------------------+---------> |
| 0 50 150 200 |
| MAP (mmHg) |
+-------------------------------------------------------------------------+
Autoregulation Dynamics
- Autoregulation Range: In normotensive adults, CBF is maintained constant across Mean Arterial Pressures of (or CPP ).
- Rightward Curve Shift in Chronic Hypertension: Long-standing hypertension causes arteriolar hypertrophy, shifting the autoregulation curve to the right (e.g., ). Lowering blood pressure into a "normal" range () can precipitate cerebral hypoperfusion and ischemic stroke in these patients.
Determinants & Modulators of CBF
- Responsiveness: Between of , CBF changes in a linear fashion by per change in (or change in CBF per mmHg).
- Hyperventilation (): Rapidly lowers ICP via cerebral vasoconstriction. Effects diminish after due to renal/CSF bicarbonate buffering. Excessive hyperventilation () induces severe cerebral ischemia.
- Responsiveness: CBF does not significantly change until falls below , at which point profound arterial vasodilation occurs to prevent tissue hypoxia.
- Temperature: CBF and decrease by for every decrease in brain temperature. At temperatures below , the electroencephalogram (EEG) becomes isoelectric.
- Anesthetic Agent Effects (Coupling vs. Uncoupling):
- IV Anesthetics (Propofol, Etomidate, Barbiturates): Produce coupled reductions in both and CBF, decreasing intracranial blood volume and lowering ICP. (Ketamine is an exception: increases CBF and ).
- Volatile Anesthetics (Isoflurane, Sevoflurane, Desflurane): Cause intrinsic dose-dependent cerebral vasodilation while decreasing . At concentrations , intrinsic vasodilation overcomes metabolic depression (uncoupling), leading to increased CBF and ICP.
2. Intracranial Dynamics & The Monro-Kellie Doctrine
+-------------------------------------------------------------------------+
| MONRO-KELLIE HYPOTHESIS |
+-------------------------------------------------------------------------+
| Rigid Skull Vault = Brain Tissue (80%) + Blood (10%) + CSF (10%) |
| |
| An increase in the volume of one cranial component must be offset |
| by a compensatory decrease in another, or ICP will exponentially rise. |
+-------------------------------------------------------------------------+
- Normal Intracranial Pressure (ICP): . Intracranial hypertension is defined as sustained ICP .
- Cerebral Perfusion Pressure (CPP):
- Target CPP in Neurological Injury: (avoid to prevent ischemia; avoid to prevent vasogenic edema and ARDS).
Cushing's Triad
A late, life-threatening manifestation of severely elevated ICP and impending transtentorial herniation:
- Hypertension (with widened pulse pressure)
- Bradycardia (reflex vagal response to severe systemic hypertension)
- Irregular Respirations / Respiratory Depression (brainstem compression)
Cerebrospinal Fluid (CSF) Kinetics
- Production: Formed by ependymal cells of the choroid plexus at a rate of (). Total adult CSF volume is .
- Flow & Absorption: Lateral ventricles Foramen of Monro 3rd Ventricle Cerebral Aqueduct of Sylvius 4th Ventricle Foramina of Luschka & Magendie Subarachnoid space Absorbed via arachnoid villi/granulations into the superior sagittal sinus.
3. Autonomic Nervous System Receptors & Second Messengers
| Receptor | G-Protein | Primary Second Messenger | Primary Organ Locations | Physiologic Actions |
|---|---|---|---|---|
| Vascular smooth muscle, radial pupillary muscle, bladder sphincter | Vasoconstriction (), mydriasis, urinary retention | |||
| Presynaptic nerve terminals, CNS locus coeruleus, platelets | Sympatholysis ( release), sedation, analgesia, platelet aggregation | |||
| SA node, AV node, myocardium, juxtaglomerular cells | Inotropy, chronotropy, dromotropy, renin release | |||
| Bronchial smooth muscle, vascular smooth muscle, uterus | Bronchodilation, vasodilation, uterine relaxation, hypokalemia ( intracellular shift) | |||
| Adipose tissue, urinary bladder detrusor | Lipolysis, detrusor relaxation (mirabegron) | |||
| SA and AV nodes of the heart | Heart rate (negative chronotropy), conduction velocity | |||
| Bronchial tree, salivary/gastric glands, ciliary muscle | Bronchoconstriction, profuse secretions, salivation, miosis |
4. Autonomic Dysreflexia (Hyperreflexia)
- Etiology: Occurs in patients with spinal cord transection at or above the T6 level (rare below T10) after the acute spinal shock phase has resolved (typically weeks to months post-injury; incidence in lesions above T6).
- Pathophysiologic Cascade:
- Cutaneous or visceral noxious stimulation below the cord lesion (most commonly bladder distension , bowel impaction, surgical manipulation, uterine contractions).
- Triggers massive, uninhibited sympathetic discharge from the isolated isolated spinal cord below the level of injury.
- Intense splanchnic and peripheral arteriolar vasoconstriction produces severe, paroxysmal systemic hypertension.
- Carotid and aortic baroreceptors detect severe hypertension, triggering compensatory vagal efferent discharge bradycardia and cutaneous vasodilation above the level of the lesion (flushing, diaphoresis, headache, nasal congestion).
- Central descending inhibitory impulses are blocked from traversing the injured spinal cord, perpetuating vasoconstriction below T6.
- Complications: Intracranial hemorrhage, encephalopathy, seizures, acute pulmonary edema, lethal ventricular arrhythmias.
- Anesthetic Management:
- General anesthesia or deep spinal anesthesia (which effectively blocks the afferent sensory limb) prevents autonomic hyperreflexia during surgery even in patients with complete sensory loss.
- First-line emergency treatment: Remove noxious stimulus, deepen anesthetic depth, and administer rapidly acting vasodilators (sodium nitroprusside, nitroglycerin, nicardipine).
5. Neuromuscular Junction Pathology: Myasthenia Gravis vs. Lambert-Eaton
+------------------------------------+-------------------------------------+
| MYASTHENIA GRAVIS (MG) | LAMBERT-EATON SYNDROME (LEMS) |
+------------------------------------+-------------------------------------+
| Postsynaptic AChR Autoantibodies | Presynaptic P/Q-Type VGCC Antibodies|
| Weakness WORSENS with exertion | Weakness IMPROVES with exercise |
| Associated with Thymoma (75%) | Associated with SCLC (>60%) |
| Resistant to Succinylcholine | SENSITIVE to Succinylcholine |
| Exquisitely SENSITIVE to NDNMBAs | Exquisitely SENSITIVE to NDNMBAs |
+------------------------------------+-------------------------------------+
| Diagnostic / Clinical Feature | Myasthenia Gravis (MG) | Lambert-Eaton Myasthenic Syndrome (LEMS) |
|---|---|---|
| Pathologic Site & Mechanism | Autoantibodies destroy postsynaptic nicotinic acetylcholine receptors (AChR) (reduces functional receptors by ) | Autoantibodies destroy presynaptic voltage-gated calcium channels (P/Q-type VGCC), preventing calcium influx and ACh exocytosis |
| Clinical Presentation | Extraocular/bulbar weakness (ptosis, diplopia, dysphagia); weakness worsens with repetitive exercise and at the end of the day | Proximal lower limb weakness; muscle strength improves with repeated contraction; autonomic dysfunction (dry mouth, orthostasis) |
| Associated Pathology | Thymic hyperplasia () or Thymoma () | Small Cell Lung Carcinoma (SCLC) in of cases (paraneoplastic) |
| Response to Succinylcholine | RESISTANT (requires higher dose, , though anticholinesterase medications can prolong duration) | SENSITIVE (marked prolongation of action) |
| Response to Non-Depolarizers | EXQUISITELY SENSITIVE (reduce dose by or avoid entirely; Sugammadex is the reversal agent of choice) | EXQUISITELY SENSITIVE (reduce dose markedly or avoid; poor response to anticholinesterases) |
| Pharmacotherapy | Pyridostigmine (oral anticholinesterase), corticosteroids, plasmapheresis, IVIG | 3,4-Diaminopyridine (Amifampridine: blocks presynaptic channels, prolonging action potential), IVIG |
A 32-year-old female with a 4-year history of Myasthenia Gravis treated with Pyridostigmine is scheduled for a transsternal thymectomy. Which of the following statements regarding the pharmacodynamic response to neuromuscular blocking agents in this patient is accurate?
She will exhibit marked resistance to non-depolarizing relaxants and heightened sensitivity to succinylcholine
She will require standard doses of cisatracurium but will experience complete resistance to sugammadex reversal
She will exhibit rapid onset and shortened duration of succinylcholine due to enhanced plasma cholinesterase activity
She will exhibit resistance to succinylcholine and marked hypersensitivity to non-depolarizing neuromuscular blockers
During an intracranial tumor resection under general anesthesia, the neurosurgeon notes brain swelling and asks for interventions to acutely reduce intracranial pressure. The patient's current arterial blood gas reveals a PaCO₂ of 45 mmHg and PaO₂ of 120 mmHg. By what mechanism will hyperventilating the patient to a PaCO₂ of 32 mmHg lower intracranial pressure?
Activation of systemic baroreceptors triggering reflex reductions in Mean Arterial Pressure
Respiratory alkalosis-induced cerebral arteriolar vasoconstriction reducing cerebral blood flow and intracranial blood volume
Stimulation of arachnoid villi ependymal transport, doubling the rate of CSF resorption
Inhibition of the cerebral metabolic rate for oxygen (CMRO₂) by 50%
A 28-year-old male with a complete T4 spinal cord transection sustained 8 months ago undergoes cystoscopy. Ten minutes into the procedure under light sedation, his blood pressure surges from 118/72 mmHg to 215/120 mmHg, his heart rate drops from 74 bpm to 44 bpm, and he develops facial flushing and profuse diaphoresis on his forehead. What is the definitive mechanism responsible for his bradycardia?
Direct parasympathetic efferent outflow triggered by spinal reflex circuits below the T4 transection
Sympathetic hyperactivation of cardiac beta-1 receptors in the sinoatrial node
Carotid and aortic baroreceptor-mediated vagal efferent discharge via the glossopharyngeal and vagus nerves in response to severe hypertension
Direct mechanical compression of the medullary vasomotor center by elevated CSF pressure
A 62-year-old male with a heavy smoking history and recently diagnosed small cell lung carcinoma presents with proximal lower extremity weakness and dry mouth. Physical examination shows hyporeflexia that temporarily improves following 10 seconds of maximal isometric quadriceps contraction. Which neuromuscular blocker profile is expected during anesthesia induction?
Marked sensitivity to both succinylcholine and non-depolarizing neuromuscular blocking agents
Resistance to non-depolarizing muscle relaxants and standard response to succinylcholine
Standard response to non-depolarizing relaxants and resistance to succinylcholine
Resistance to both depolarizing and non-depolarizing neuromuscular blocking agents
Sections you finish are checked off in the contents.